The effects of an oral supplement enriched with fish oil, prebiotics, and antioxidants on nutrition status in Crohn's disease patients.

Wiese DM, Lashner BA, Lerner E, DeMichele SJ, Seidner DL
Nutr Clin Pract. 2011 26 (4): 463-73

PMID: 21775642 · PMCID: PMC4457393 · DOI:10.1177/0884533611413778

BACKGROUND - Research in the treatment of Crohn's disease (CD) supports anti-inflammatory benefits of n-3 fatty acids from fish oil, prebiotics, and antioxidants. A nutritionally balanced inflammatory bowel disease nutrition formula (IBDNF) enriched with these compounds has the potential to improve nutrition status and disease activity in CD.

METHODS - This is an open-label pilot study investigating the effects of IBDNF on nutrition status in CD patients. Twenty-eight patients with active CD on stable medication were asked to consume 16 oz of IBDNF/d for 4 months. Nutrition status was assessed with dual-energy X-ray absorptiometry scans and serum micronutrient levels. Disease activity and quality of life were measured using the Crohn's Disease Activity Index (CDAI) and the Inflammatory Bowel Disease Questionnaire (IBDQ).

RESULTS - Twenty patients completed the final visit. After 4 months, there was a significant decrease in plasma phospholipid levels of arachidonic acid with increases in eicosapentaenoic acid (EPA) and docosahexaenoic acid. Ten patients had a final EPA concentration of >2%. There was improvement in fat-free and fat mass in patients with final EPA >2% (P = .014 and P = .05). Vitamin D (25-OH) levels improved in all patients (18.5-25.9 ng/mL, P < .001). Those with EPA >2% had significantly lower CDAI (116 ± 94.5 vs 261.8 ± 86.5; P = .005) and higher IBDQ (179.1 ± 26.6 vs 114.6 ± 35.9, P < .001) compared to those with EPA <2%.

CONCLUSIONS - IBDNF has the potential to deposit fat-free and fat mass, improve vitamin D status, and improve quality of life in CD patients.

MeSH Terms (28)

Adipose Tissue Administration, Oral Adult Aged Antioxidants Arachidonic Acid Body Fluid Compartments Crohn Disease Dietary Fiber Dietary Supplements Docosahexaenoic Acids Drug Combinations Eicosapentaenoic Acid Fatty Acids, Omega-3 Fatty Acids, Unsaturated Female Fish Oils Humans Male Middle Aged Nutritional Status Phospholipids Pilot Projects Prebiotics Severity of Illness Index Surveys and Questionnaires Vitamin D Young Adult

Connections (1)

This publication is referenced by other Labnodes entities: